Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention (STATUS PCI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01464671
Recruitment Status : Terminated (DSMB halted the study early due to futility. There were no safety concerns.)
First Posted : November 3, 2011
Last Update Posted : November 20, 2014
Information provided by (Responsible Party):
Allen Jeremias, Stony Brook University

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 2014
  Actual Study Completion Date : September 2014